Literature DB >> 29419850

[Discussion on the standard of clinical genetic testing report and the consensus of gene testing industry].

Hui Huang1, Yiping Shen, Weihong Gu, Wei Wang, Yiming Wang, Ming Qi, Jun Shen, Zhengqing Qiu, Shihui Yu, Zaiwei Zhou, Baixue Chen, Lei Chen, Yundi Chen, Huanhuan Cui, Juan Du, Yong Gao, Yiran Guo, Chanjuan Hu, Liang Hu, Yi Huang, Peipei Li, Xiaorong Li, Xiurong Li, Yaping Liu, Jie Lu, Duan Ma, Yongyi Ma, Mei Peng, Fang Song, Hongye Sun, Liang Wang, Dawei Wang, Jingmin Wang, Ling Wang, Zhengyuan Wang, Zhinong Wang, Jihong Wu, Jing Wu, Jian Wu, Yimin Xu, Hong Yao, Dongsheng Yang, Xu Yang, Yanling Yang, Ying Zhang, Yulin Zhou, Baosheng Zhu, Sicong Zeng, Zhiyu Peng, Shangzhi Huang.   

Abstract

The widespread application of next generation sequencing (NGS) in clinical settings has enabled testing, diagnosis, treatment and prevention of genetic diseases. However, many issues have arisen in the meanwhile. One of the most pressing issues is the lack of standards for reporting genetic test results across different service providers. The First Forum on Standards and Specifications for Clinical Genetic Testing was held to address the issue in Shenzhen, China, on October 28, 2017. Participants, including geneticists, clinicians, and representatives of genetic testing service providers, discussed problems of clinical genetic testing services across in China and shared opinions on principles, challenges, and standards for reporting clinical genetic test results. Here we summarize expert opinions presented at the seminar and report the consensus, which will serve as a basis for the development of standards and guidelines for reporting of clinical genetic testing results, in order to promote the standardization and regulation of genetic testing services in China.

Entities:  

Mesh:

Year:  2018        PMID: 29419850     DOI: 10.3760/cma.j.issn.1003-9406.2018.01.001

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  4 in total

1.  Experience of Low-Pass Whole-Genome Sequencing-Based Copy Number Variant Analysis: A Survey of Chinese Tertiary Hospitals.

Authors:  Yu Zheng; Baosheng Zhu; Jichun Tan; Yichun Guan; Cynthia C Morton; Guangxiu Lu
Journal:  Diagnostics (Basel)       Date:  2022-04-27

2.  Genetic Privacy and Data Protection: A Review of Chinese Direct-to-Consumer Genetic Test Services.

Authors:  Li Du; Meng Wang
Journal:  Front Genet       Date:  2020-04-28       Impact factor: 4.599

3.  [Chinese Expert Consensus on Next Generation Sequencing Diagnosis 
for Non-small Cell Lung Cancer (2020 Edition)].

Authors: 
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-09-20

4.  [Expert consensus on laboratory standardized technical specifications for monitoring minimal residual disease using next-generation sequencing in multiple myeloma(2021)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.